These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37173728)

  • 1. Prevalence and clinical impact of frailty in COPD: a systematic review and meta-analysis.
    Wang L; Zhang X; Liu X
    BMC Pulm Med; 2023 May; 23(1):164. PubMed ID: 37173728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of malnutrition in patients with chronic obstructive pulmonary disease: Systemic review and meta-analysis.
    Deng M; Lu Y; Zhang Q; Bian Y; Zhou X; Hou G
    Clin Nutr; 2023 Jun; 42(6):848-858. PubMed ID: 37084471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.
    Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
    BMC Pulm Med; 2020 Apr; 20(1):103. PubMed ID: 32326924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients: A meta-analysis and system review.
    Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
    Medicine (Baltimore); 2019 Nov; 98(46):e17996. PubMed ID: 31725666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis.
    Sepúlveda-Loyola W; Osadnik C; Phu S; Morita AA; Duque G; Probst VS
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1164-1176. PubMed ID: 32862514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
    Ammous O; Feki W; Lotfi T; Khamis AM; Gosselink R; Rebai A; Kammoun S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013778. PubMed ID: 36606682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could Disease Severity and Inflammatory Markers (IL-6, Hs-CRP, TNF-α) be Related to Frailty in COPD? A Prospective Study.
    R S; M N; L D; N K; G S; Kk B
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty and Clinical Outcomes in Chronic Obstructive Pulmonary Disease.
    Kennedy CC; Novotny PJ; LeBrasseur NK; Wise RA; Sciurba FC; Benzo RP
    Ann Am Thorac Soc; 2019 Feb; 16(2):217-224. PubMed ID: 30433830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD.
    Hanlon P; Guo X; McGhee E; Lewsey J; McAllister D; Mair FS
    NPJ Prim Care Respir Med; 2023 Jan; 33(1):1. PubMed ID: 36604427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test.
    Neo HY; Xu HY; Wu HY; Hum A
    J Palliat Med; 2017 Aug; 20(8):821-828. PubMed ID: 28353374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty and its influence on mortality and morbidity in COPD: A Systematic Review and Meta-Analysis.
    Verduri A; Carter B; Laraman J; Rice C; Clini E; Maskell NA; Hewitt J
    Intern Emerg Med; 2023 Nov; 18(8):2423-2434. PubMed ID: 37668748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily living activities, exercise capacity, cognition, and balance in COPD patients with and without frailty.
    Kagiali S; Inal-Ince D; Cakmak A; Calik-Kutukcu E; Saglam M; Vardar-Yagli N; Tekerlek H; Sonbahar-Ulu H; Arikan H; Bozdemir-Ozel C; Coplu L
    Ir J Med Sci; 2022 Apr; 191(2):817-824. PubMed ID: 34028643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of frailty in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis.
    Yan LC; Lu HY; Wang XY; Xiao G; Chang Y; Yuan P; Wang B
    Eur Geriatr Med; 2023 Aug; 14(4):789-802. PubMed ID: 37436687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Impact of Social Frailty in Patients with Chronic Obstructive Pulmonary Disease.
    Hirai K; Tanaka A; Oda N; Kaneko K; Uchida Y; Uno T; Ohta S; Homma T; Yamaguchi F; Suzuki S; Sagara H
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2117-2126. PubMed ID: 37780032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-based exercise training for chronic obstructive pulmonary disease.
    McNamara RJ; McKeough ZJ; McKenzie DK; Alison JA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008290. PubMed ID: 24353107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated disease management interventions for patients with chronic obstructive pulmonary disease.
    Kruis AL; Smidt N; Assendelft WJ; Gussekloo J; Boland MR; Rutten-van Mölken M; Chavannes NH
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009437. PubMed ID: 24108523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of thoracic pain in patients with chronic obstructive pulmonary disease and relationship with patient characteristics: a cross-sectional observational study.
    Janssen DJ; Wouters EF; Parra YL; Stakenborg K; Franssen FM
    BMC Pulm Med; 2016 Apr; 16():47. PubMed ID: 27052199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.